Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression. - Wikidata - wikimedia - TriplyDB

Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.

Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.

http://www.wikidata.org/entity/Q36447669

about

Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment Preoperative platelet lymphocyte ratio as independent predictors of prognosis in pancreatic cancer: A systematic review and meta-analysis.Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer Clinicopathological and prognostic significance of platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma.Identification of TWIST-interacting genes in prostate cancer.CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate Cancer.Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps.Neutrophils in cancer: neutral no more.YAP/TAZ at the Roots of Cancer.Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies.CAR T-cell therapy of solid tumors.Hippo vs. Crab: tissue-specific functions of the mammalian Hippo pathway.Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer.CD133 Regulates IL-1β Signaling and Neutrophil Recruitment in Glioblastoma.Platelets reduce anoikis and promote metastasis by activating YAP1 signaling.Effective combinatorial immunotherapy for castration-resistant prostate cancer Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma.Single tumor-initiating cells evade immune clearance by recruiting type II macrophages.CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma.Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM).Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities.Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells.PRKCI promotes immune suppression in ovarian cancer.Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms.TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs.Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients.YAP1 regulates prostate cancer stem cell-like characteristics to promote castration resistant growth.Soft-shelled turtle peptide modulates microRNA profile in human gastric cancer AGS cells.Opposing roles of TGFβ and BMP signaling in prostate cancer development.MiRNAs at the Crossroads between Innate Immunity and Cancer: Focus on Macrophages.Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesothelioma.The Hippo Pathway: Immunity and Cancer.Infiltrating Myeloid Cells Exert Protumorigenic Actions via Neutrophil Elastase.YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting.YAP/TAZ Activation as a Target for Treating Metastatic Cancer.Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8+ T Cells, Regulatory T Cells, and Myeloid-Derived Suppressor Cells in Soft Tissue Sarcoma.Tumor-infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer.

P2860

Q28078129-16868524-720D-441F-8AE7-DE969E1F9CD9 Q28388630-689AFFB5-FBBC-4829-9018-8727A532CCDC Q36390876-5FEB3C59-43BD-4EF9-9720-F40977333F8B Q37580326-C7F7807E-83CE-4621-9617-DA93BF83E2B6 Q37697228-0D6CEC70-E039-4079-8F27-9F9573A37185 Q38719560-921B7F46-B068-4504-A6BC-D91B08FB1871 Q38741840-05E5C6BF-405A-4642-94D8-0559675354FF Q38768422-C4DC42F4-65FE-460A-834E-A91ED19C74AD Q38845812-A344C23F-D098-4C96-8760-7A0E730F5FD7 Q38860382-4E372375-7C88-447A-8961-EAD4E0C629FE Q38864941-376A77E0-4CB9-44B5-87AC-22C96C9E5F85 Q39003420-57FE3742-15EC-4BD8-AFA1-6666B3A1D87E Q39047856-797F6E6F-854D-46DA-A08F-F0D052B2F133 Q39081825-3E7E406A-513B-472E-8767-50A3120D5D3C Q39321350-9F46849A-F9FB-4717-B2E8-D8B290742183 Q39438805-3E34610E-05D1-43E7-A1B4-860A3BC29964 Q41288638-48C43653-6F0F-43E3-8731-3242B7B06CC9 Q41484257-06E62521-951E-47CB-9A60-13090602F9EF Q41716558-609F74DB-2252-4F36-B9B1-02D8DF3CBA53 Q41858851-01366044-7A2C-43DD-80A1-245818C887AE Q41957741-27033619-A1C2-4C3E-86B7-AF74698779A8 Q42697314-6F96003E-E8D7-4F1D-92EB-23FDA7593BC8 Q45822425-98492114-2F4F-4DB7-AFB9-72DE754FC7C3 Q45832774-C8289D66-C258-41C6-86CF-02EBC8603E90 Q46302561-52126EE9-433E-4BEF-B644-23328B187F47 Q47154650-391D50BE-66F1-4A62-8C3F-A8B15A6C01D2 Q47198804-7E475EE2-CCC3-4F27-8961-AA4C71F3CC63 Q47575245-CEE3CACF-4BFB-4F14-9909-A44DFC606619 Q49501422-DA08EAD1-2F2B-4556-8718-39FBC04696F7 Q49569440-F82D67B1-A9DB-43FD-BB3C-36C2A7EDAA80 Q49714381-E6F63B3F-10D0-420C-AA1F-863CC9FC703B Q49912287-0729B048-E3FC-4349-B6CF-8E5F4D3459D1 Q50117508-7D6AE079-5123-42A6-8C7D-4EAAAB7901B5 Q51416101-5D93A817-9360-4E57-ABEE-19DC713C97CC Q52621407-878A4BF9-71FB-4122-95A1-5193F7FA6F8A Q52770285-EB9AC855-67FF-4FFC-8B73-30770BCB9D88 Q53686708-C2C326BF-85FF-4ECA-8A29-930A3C0D0389 Q54977387-EC94F33E-3296-46F3-B876-5C7EA2204FCD Q55275991-58B6C4B8-C5D2-4785-A5C4-66BE4883B2D5 Q55484842-265DE384-8550-461F-A012-4643ED0E0777

P2860

Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.

http://www.wikidata.org/entity/Q36447669

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.

@ast

Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.

@en

type

label

Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.

@ast

Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.

@en

prefLabel

Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.

@ast

Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.

@en

P1433

Q36447669-E74A5665-5D73-4980-A130-86C78AADDC39

P1476

Q36447669-773DB369-5A46-43D7-BEC5-F196FDFB9AF8

P2093

Q36447669-03FCE5B0-4461-42B1-8E8B-815827EE9148

Q36447669-07D712FB-1ED0-496D-B2DF-C6544E7C2A70

Q36447669-0845ADC4-299A-45A8-8DEF-BB53F950679F

Q36447669-0FB4651F-1973-4B85-9505-CD73219CE45C

Q36447669-1701E476-AC35-4826-A637-74D9A1D34E46

Q36447669-1E61BA9A-882C-4994-8CC1-E644CDB833E2

Q36447669-1EEEBEA0-F2D4-4E09-925F-254DC007C897

Q36447669-2D187A7D-8E58-4CDC-8FD8-EBC86C4A3CA7

Q36447669-3AFAFB0A-3BAE-45FC-B1F5-7D3824900DB4

Q36447669-42BC1E47-A33D-45CD-B4F5-B1E4E069ACE3

P2860

Q36447669-01801595-62A3-4330-B779-98F12C1511D1

Q36447669-09F58175-A08E-4106-8B12-32E6C76437CB

Q36447669-1048C363-4E5E-40DF-9931-132AABD7D97D

Q36447669-10CB4121-5742-4753-9267-8B0083F0F6EF

Q36447669-26376E20-5750-4730-B8B4-467B4AFCB7BD

Q36447669-29F60939-3718-4485-9CE2-B20CE4543C94

Q36447669-31ABB4FC-26A5-4EC7-BD63-D62C7F7F83F0

Q36447669-3B07C277-0E32-434C-95E4-53A0E0716292

Q36447669-4E55C56C-B42F-4928-AC20-B4916EE59F51

Q36447669-4EB51BB3-4C64-4F66-B734-608DB2A9CD97

P304

Q36447669-C2FDF5B6-E66A-4D50-8D45-061774DCCC3B

P31

Q36447669-A6B514EF-4E80-40DD-A88C-F480BE129968

P356

Q36447669-9EB836CA-E23E-4FB7-914E-03E4A075DBD3

P433

Q36447669-353B609C-3A38-45F0-B9A8-E23FBF429708

P478

Q36447669-4C175F3D-B1C4-4483-AD18-C8E4045A6414

P50

Q36447669-B84BB6F5-8EF3-469C-A3AD-F1F2F9DD6DEB

P577

Q36447669-44108526-74B8-42A9-BC88-1F50D8628CA0

P698

Q36447669-068DF035-F260-41C6-BFA4-FFA8121B0675

P932

Q36447669-33E08CAF-C522-4FAF-B667-11ED1AA7A199

P356

2159-8290.CD-15-0224

P1433

Cancer Discovery

P1476

Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.

@en

P2093

Avnish Kapoor

http://www.w3.org/2001/XMLSchema#string

Baoli Hu

http://www.w3.org/2001/XMLSchema#string

Chang-Jiun Wu

http://www.w3.org/2001/XMLSchema#string

Chia Chin Wu

http://www.w3.org/2001/XMLSchema#string

Christopher J Logothetis

http://www.w3.org/2001/XMLSchema#string

Di Zhao

http://www.w3.org/2001/XMLSchema#string

Elsa M Li-Ning-Tapia

http://www.w3.org/2001/XMLSchema#string

Eun-Jung Jin

http://www.w3.org/2001/XMLSchema#string

Guocan Wang

http://www.w3.org/2001/XMLSchema#string

Jianhua Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment

Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor

Coordinated regulation of myeloid cells by tumours

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

A global double-fluorescent Cre reporter mouse

Influence of tumour micro-environment heterogeneity on therapeutic response

Accessories to the crime: functions of cells recruited to the tumor microenvironment

Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.

P304

80-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/2159-8290.CD-15-0224

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26701088

http://www.w3.org/2001/XMLSchema#string

P932

4707102

http://www.w3.org/2001/XMLSchema#string